Current Therapy of Acquired Ocular Toxoplasmosis: A Review

Journal of Ocular Pharmacology and Therapeutics

Volumn 31, Issue 9, 2015, Pages 511-517

  Cerqueira Lima, Guilherme Sturzeneker ^a   Saraiva, Patricia Grativol Costa ^b   Saraiva, Fábio Petersen ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Medicine Department   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIPARASITIC AGENT; CORTICOSTEROID; ANTIPROTOZOAL AGENT;

HUMAN; MORBIDITY; NONHUMAN; OPHTHALMOLOGIST; REVIEW; RISK REDUCTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT OUTCOME; UVEITIS; ANIMAL; ISOLATION AND PURIFICATION; PARASITOLOGY; TOXOPLASMA; TOXOPLASMOSIS, OCULAR;

ANIMALS; ANTIPROTOZOAL AGENTS; HUMANS; TOXOPLASMA; TOXOPLASMOSIS, OCULAR;

EID: 84946414991     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2015.0059     Document Type: Review

References (95)

1. Silveira, C., Belfort, R., Jr., Burnier, M., Jr., and Nussenblatt, R. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am. J. Ophthalmol. 106:362-364, 1988.
2. Montoya, J.G., and Liesenfeld, O. Toxoplasmosis. Lancet 363:1965-1976, 2004.
3. Vallochi, A.L., Muccioli, C., Martins, M.C., et al. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am. J. Ophthalmol. 139:350-351, 2005.
4. Gilbert, R.E., See, S.E., Jones, L.V., and Stanford, M.S. Antibiotics versus control for toxoplasma retinochoroiditis. Cochrane Database Syst. Rev. CD002218, 2002.
5. Bonametti, A.M., Passos Jdo, N., da Silva, E.M., and Bortoliero, A.L. [Outbreak of acute toxoplasmosis transmitted thru the ingestion of ovine raw meat]. Rev. Soc. Bras. Med. Trop. 30:21-25, 1996.
6. Garcia, J.L., Navarro, I.T., Ogawa, L., et al. [Seroepidemiology of toxoplasmosis and ocular evaluation by Amsler grid in patients from the rural area treated at the Jaguapita county health center, Parana State, Brazil]. Rev. Soc. Bras. Med. Trop. 32:671-676, 1999.
7. Dunn, D., Wallon, M., Peyron, F., et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829-1833, 1999.
8. Guerina, N.G. Congenital infection with Toxoplasma gondii. Pediatr. Ann. 23:138-142, 147-151, 1994.
9. Meenken, C., Assies, J., van Nieuwenhuizen, O., et al. Long term ocular and neurological involvement in severe congenital toxoplasmosis. Br. J. Ophthalmol. 79:581-584, 1995.
10. Orefice, F., and Bahia-Oliveira, L.M. Toxoplasmose. In:Orefice, F., ed. Uveíte Clínica e Cirúrgica. Rio de Janeiro: Cultura Médica; 2005; pp. 699-804.
11. Holland, G.N. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am. J. Ophthalmol. 136:973-988, 2003.
12. Benenson, M.W., Takafuji, E.T., Lemon, S.M., Greenup, R.L., and Sulzer, A.J. Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N. Engl. J. Med. 307:666-669, 1982.
13. Bowie, W.R., King, A.S., Werker, D.H., et al. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet 350:173-177, 1997.
14. Burnett, A.J., Shortt, S.G., Isaac-Renton, J., et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 105:1032-1037, 1998.
15. de Moura, L., Bahia-Oliveira, L.M., Wada, M.Y., et al. Waterborne toxoplasmosis, Brazil, from field to gene. Emerg. Infect. Dis. 12:326-329, 2006.
16. Bahia-Oliveira, L.M., Jones, J.L., Azevedo-Silva, J., et al. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg. Infect. Dis. 9:55-62, 2003.
17. Pena, H.F., Gennari, S.M., Dubey, J.P., and Su, C. Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int. J. Parasitol. 38:561-569, 2008.
18. Howe, D.K., and Sibley, L.D. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis. 172:1561-1566, 1995.
19. Ajzenberg, D., Banuls, A.L., Su, C., et al. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int. J. Parasitol. 34:1185-1196, 2004.
20. Lehmann, T., Graham, D.H., Dahl, E.R., et al. Variation in the structure of Toxoplasma gondii and the roles of selfing, drift, and epistatic selection in maintaining linkage disequilibria. Infect. Genet. Evol. 4:107-114, 2004.
21. Ajzenberg, D., Cogne, N., Paris, L., et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J. Infect. Dis. 186:684-689, 2002.
22. Howe, D.K., Honore, S., Derouin, F., and Sibley, L.D. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J. Clin. Microbiol. 35:1411-1414, 1997.
23. Nowakowska, D., Colon, I., Remington, J.S., et al. Genotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis. J. Clin. Microbiol. 44:1382-1389, 2006.
24. Dubey, J.P., Gennari, S.M., Labruna, M.B., et al. Characterization of Toxoplasma gondii isolates in free-range chickens from Amazon, Brazil. J. Parasitol. 92:36-40, 2006.
25. Yai, L.E., Ragozo, A.M., Soares, R.M., et al. Genetic diversity among capybara (Hydrochaeris hydrochaeris) isolates of Toxoplasma gondii from Brazil. Vet. Parasitol. 162:332-337, 2009.
26. Jones, J.L., Muccioli, C., Belfort, R., Jr., et al. Recently acquired Toxoplasma gondii infection, Brazil. Emerg. Infect. Dis. 12:582-587, 2006.
27. Khan, A., Jordan, C., Muccioli, C., et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg. Infect. Dis. 12:942-949, 2006.
28. Belfort, R.N., Rasmussen, S., Kherani, A., et al. Bilateral progressive necrotizing retinochoroiditis in an immunocompromised patient: histopathological diagnosis. Acta Ophthalmol. 88:614-615, 2010.
29. Montoya, J.G., and Remington, J.S. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin. Infect. Dis. 23:277-282, 1996.
30. Nussenblatt, R.B., and Belfort, R., Jr. Ocular toxoplasmosis. An old disease revisited. JAMA 271:304-307, 1994.
31. Eckert, G.U., Melamed, J., and Menegaz, B. Optic nerve changes in ocular toxoplasmosis. Eye (Lond). 21:746-751, 2007.
32. Holland, G.N. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am. J. Ophthalmol. 137:1-17, 2004.
33. Jasper, S., Vedula, S.S., John, S.S., et al. Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Cochrane Database Syst. Rev. 4:CD007417, 2013.
34. Bonfioli, A.A., and Orefice, F. Toxoplasmosis. Semin. Ophthalmol. 20:129-141, 2005.
35. Smith, J.R., and Cunningham, E.T., Jr. Atypical presentations of ocular toxoplasmosis. Curr. Opin. Ophthalmol. 13:387-392, 2002.
36. Bosch-Driessen, L.H., Karimi, S., Stilma, J.S., and Rothova, A. Retinal detachment in ocular toxoplasmosis. Ophthalmology 107:36-40, 2000.
37. Toledo de Abreu, M., Belfort, R., Jr., and Hirata, P.S. Fuchs' heterochromic cyclitis and ocular toxoplasmosis. Am. J. Ophthalmol. 93:739-744, 1982.
38. Ganesh, S.K., Sharma, S., Narayana, K.M., and Biswas, J. Fuchs' heterochromic iridocyclitis following bilateral ocular toxoplasmosis. Ocul. Immunol. Inflamm. 12:75-77, 2004.
39. La Hey, E., and Baarsma, G.S. Contralateral active ocular toxoplasmosis in Fuchs' heterochromic cyclitis. Br. J. Ophthalmol. 77:455-456, 1993.
40. Schwab, I.R. The epidemiologic association of Fuchs' heterochromic iridocyclitis and ocular toxoplasmosis. Am. J. Ophthalmol. 111:356-362, 1991.
41. Silveira, C., Belfort, R., Jr., Muccioli, C., et al. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am. J. Ophthalmol. 131:351-354, 2001.
42. Holland, G.N., Crespi, C.M., ten Dam-van Loon, N., et al. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am. J. Ophthalmol. 145:1007-1013, 2008.
43. Garweg, J.G., Scherrer, J.N., and Halberstadt, M. Recurrence characteristics in European patients with ocular toxoplasmosis. Br. J. Ophthalmol. 92:1253-1256, 2008.
44. Bosch-Driessen, L.E., Berendschot, T.T., Ongkosuwito, J.V., and Rothova, A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109:869-878, 2002.
45. Bosch-Driessen, E.H., and Rothova, A. Recurrent ocular disease in postnatally acquired toxoplasmosis. Am. J. Ophthalmol. 128:421-425, 1999.
46. Abreu, M.T., Belfort R., Jr., and Orefice, F. Toxoplasmose ocular. In: Orefice, F., and Belfort R., Jr., eds. Uveítes. São Paulo: Roca; 1987; pp. 211-230.
47. Silveira, C., Vallochi, A.L., Rodrigues da Silva, U., et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br. J. Ophthalmol. 95:396-400, 2011.
48. Silveira, C., Belfort, R., Jr., Muccioli, C., et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am. J. Ophthalmol. 134:41-46, 2002.
49. Ongkosuwito, J.V., Bosch-Driessen, E.H., Kijlstra, A., and Rothova, A. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am. J. Ophthalmol. 128:407-412, 1999.
50. Rao, N.A., and Font, R.L. Toxoplasmic retinochoroiditis: electron-microscopic and immunofluorescence studies of formalin-fixed tissue. Arch Ophthalmol. 95:273-277, 1977.
51. Brezin, A.P., Egwuagu, C.E., Burnier, M., Jr., et al. Identification of Toxoplasma gondii in paraffin-embedded sections by the polymerase chain reaction. Am. J. Ophthalmol. 110:599-604, 1990.
52. Belfort, R.N., Fernandes, B.F., Romano, A., et al. Bilateral macular hemorrhage as a complication of drug-induced anemia: a case report. J. Med. Case Rep. 3:16, 2009.
53. Montoya, J.G., Parmley, S., Liesenfeld, O., Jaffe, G.J., and Remington, J.S. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology 106:1554-1563, 1999.
54. Rothova, A., de Boer, J.H., Ten Dam-van Loon, N.H., et al. Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Ophthalmology 115:306-311, 2008.
55. Grigg, M.E., Ganatra, J., Boothroyd, J.C., and Margolis, T.P. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 184:633-639, 2001.
56. Fekkar, A., Bodaghi, B., Touafek, F., et al. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J. Clin. Microbiol. 46:1965-1967, 2008.
57. Goldman, M. Staining toxoplasma gondii with fluorescein-labelled antibody. II. A new serologic test for antibodies to Toxoplasma based upon inhibition of specific staining. J. Exp. Med. 105:557-573, 1957.
58. Calderaro, A., Piccolo, G., Gorrini, C., et al. Comparison between two real-time PCR assays and a nested-PCR for the detection of Toxoplasma gondii. Acta Biomed. 77:75-80, 2006.
59. Mahalakshmi, B., Therese, K.L., Madhavan, H.N., and Biswas, J. Diagnostic value of specific local antibody production and nucleic acid amplification technique-nested polymerase chain reaction (nPCR) in clinically suspected ocular toxoplasmosis. Ocul. Immunol. Inflamm. 14:105-112, 2006.
60. Dworkin, L.L., Gibler, T.M., and Van Gelder, R.N. Real-time quantitative polymerase chain reaction diagnosis of infectious posterior uveitis. Arch Ophthalmol. 120:1534-1539, 2002.
61. Lin, M.H., Chen, T.C., Kuo, T.T., Tseng, C.C., and Tseng, C.P. Real-time PCR for quantitative detection of Toxoplasma gondii. J. Clin. Microbiol. 38:4121-4125, 2000.
62. Rothova, A., Buitenhuis, H.J., Meenken, C., et al. Therapy of ocular toxoplasmosis. Int. Ophthalmol. 13:415-419, 1989.
63. Garweg, J.G., and Stanford, M.R. Therapy for ocular toxoplasmosis - the future. Ocul. Immunol. Inflamm. 21:300-305, 2013.
64. Kortagere, S. Screening for small molecule inhibitors of Toxoplasma gondii. Expert Opin. Drug Discov. 7:1193-1206, 2012.
65. McFadden, D.C., Camps, M., and Boothroyd, J.C. Resistance as a tool in the study of old and new drug targets in Toxoplasma. Drug Resist. Updat. 4:79-84, 2001.
66. Antoniazzi, E., Guagliano, R., Meroni, V., Pezzotta, S., and Bianchi, P.E. Ocular impairment of toxoplasmosis. Parassitologia 50:35-36, 2008.
67. Pleyer, U., Torun, N., and Liesenfeld, O. [Ocular toxoplasmosis]. Ophthalmologe 2007; 104:603-615, quiz 616.
68. Opremcak, E.M., Scales, D.K., and Sharpe, M.R. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis. Ophthalmology 99:920-925, 1992.
69. Soheilian, M., Sadoughi, M.M., Ghajarnia, M., et al. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology 112:1876-1882, 2005.
70. Bosch-Driessen, L.H., Verbraak, F.D., Suttorp-Schulten, M.S., et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am. J. Ophthalmol. 134:34-40, 2002.
71. Rothova, A., Meenken, C., Buitenhuis, H.J., et al. Therapy for ocular toxoplasmosis. Am. J. Ophthalmol. 115:517-523, 1993.
72. Holland, G.N., and Lewis, K.G. An update on current practices in the management of ocular toxoplasmosis. Am. J. Ophthalmol. 134:102-114, 2002.
73. Lum, F., Jones, J.L., Holland, G.N., and Liesegang, T.J. Survey of ophthalmologists about ocular toxoplasmosis. Am. J. Ophthalmol. 140:724-726, 2005.
74. O'Connor, G.R., and Frenkel, J.K. Editorial: dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy. Arch Ophthalmol. 94:213, 1976.
75. Kaufman, H.E. The effect of corticosteroids on experimental ocular toxoplasmosis. Am. J. Ophthalmol. 50:919-926, 1960.
76. Damms, T., Bohnke, M., and Behrend-Berdin, B. [Results of therapy in ocular toxoplasmosis. Comparison of various forms of therapy]. Ophthalmologe 90:737-741, 1993.
77. Hegab, S.M., and Al-Mutawa, S.A. Immunopathogenesis of toxoplasmosis. Clin. Exp. Med. 3:84-105, 2003.
78. Rush, R., and Sheth, S. Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration. Indian J. Ophthalmol. 60:141-143, 2012.
79. Sabates, R., Pruett, R.C., and Brockhurst, R.J. Fulminant ocular toxoplasmosis. Am. J. Ophthalmol. 92:497-503, 1981.
80. Felix, J.P., Lira, R.P., Zacchia, R.S., et al. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial. Am. J. Ophthalmol. 157:762-766.e761, 2014.
81. Morhun, P.J., Weisz, J.M., Elias, S.J., and Holland, G.N. Recurrent ocular toxoplasmosis in patients treated with systemic corticosteroids. Retina 16:383-387, 1996.
82. Huskinson-Mark, J., Araujo, F.G., and Remington, J.S. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J. Infect. Dis. 164:170-171, 1991.
83. Pearson, P.A., Piracha, A.R., Sen, H.A., and Jaffe, G.J. Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology 106:148-153, 1999.
84. Kump, L.I., Androudi, S.N., and Foster, C.S. Ocular toxoplasmosis in pregnancy. Clin. Exp. Ophthalmol. 33:455-460, 2005.
85. Gilbert, R.E., Freeman, K., Lago, E.G., et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis. 2:e277, 2008.
86. Thiebaut, R., Leproust, S., Chene, G., and Gilbert, R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369:115-122, 2007.
87. Couvreur, J., Thulliez, P., Daffos, F., et al. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine. Fetal Diagn. Ther. 8:45-50, 1993.
88. Kieffer, F., Wallon, M., Garcia, P., et al. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr. Infect. Dis. J. 27:27-32, 2008.
89. Kodjikian, L., Wallon, M., Fleury, J., et al. Ocular manifestations in congenital toxoplasmosis. Graefes Arch. Clin. Exp. Ophthalmol. 244:14-21, 2006.
90. Aggio, F.B., Muccioli, C., and Belfort, R., Jr. Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis. Eye (Lond). 20:1080-1082, 2006.
91. Sobrin, L., Kump, L.I., and Foster, C.S. Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina 27:952-957, 2007.
92. Kishore, K., Conway, M.D., and Peyman, G.A. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg. Lasers 32:183-192, 2001.
93. Martinez, C.E., Zhang, D., Conway, M.D., and Peyman, G.A. Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine. Int. Ophthalmol. 22:85-88, 1998.
94. Meneceur, P., Bouldouyre, M.A., Aubert, D., et al. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone. Antimicrob. Agents Chemother. 52:1269-1277, 2008.
95. Gomes, T.C., de Andrade Junior, H.F., Lescano, S.A., and Amato-Neto, V. In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii. Rev. Soc. Bras. Med. Trop. 45:485-490, 2012.